EAEkarini Aryasatiani

Ekarini Aryasatiani

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ekarini Aryasatiani has a total of 13 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Cervical cancer screening before hysterectomy in pelvic organ prolapse patients: Is it essential? A case series

    by Ekarini Aryasatiani, Raymond Surya, Dyonesia Ary Harjanti, Florinda Ilona, Chandra Dewi Kartika, Catalya Christina Cantika, Lisda Tenka

    HIGHLIGHTS ABSTRACT Objective: Pelvic organ prolapse (POP) is caused by a weakening of pelvic floor muscles. The prevalence of unanticipated premalignant and malignant pathologies after hysterectomy is varied from 0.2 to 0.8%. This report to present a case series of POP’s patients undergoing vaginal hysterectomy (VH) with preoperative evaluation of abnormal cervical smear ending with higher result of histopathology. Case Series: Case 1: A-55-year-old woman, P3A0 was diagnosed as third grade both in uterine prolapse and cystocele. The result of Pap smear revealed atypical glandular cells of undetermined significance (AGUS). Histopathological result after VH was vaginitis and metaplastic chronic cervicitis with atypia to mild dysplasia of endocervical epithelial cell/ low grade squamous intraepithelial lesion (LSIL). Case 2: A-62-year-old woman, P5A0, was diagnosed as third grade of uterine prolapse. The result of Pap smear showed atypical squamous cells of undetermined significance (ASCH). Histopathological result after VH was high grade squamous intraepithelial lesion (HSIL) up to in situ carcinoma with involvement of microinvasive gland and focus. Conclusion: Since cervical cancer still become the second most common cause of mortality in Indonesia, it is recommended to screen preoperatively for pre-cancerous gynecological lesion and cancer.

  • Open Access

    Evaluation and diagnostic approach in patient with Perrault Syndrome

    by Rachael Christin Nathania, Steven Yulius Usman, Ekarini Aryasatiani

    HIGHLIGHTS 1. The rare hereditary condition Perrault Syndrome is characterized by sensorineural hearing loss (SNHL) and ovarian dysfunction 2. Cyclic estrogens and progesterone may be given to adolescents with amenorrhea to induce withdrawal bleeding and mimic the menstrual cycle. ABSTRACT Objectives: A multidisciplinary team, which included a reproductive endocrinologist and an otolaryngologist, identified Perrault Syndrome in a patient with secondary amenorrhea and bilateral sensorineural hearing loss. Case Report: A 16-year-old female presented to the obstetrics and gynecology clinic at a type B hospital with primary amenorrhea for one year. Menarche occurred at age 13, followed by regular menstrual cycles for two years, after which menstruation gradually ceased. She denied dysmenorrhea, constipation, leukorrhea, genital pruritus, growth retardation, and weight loss. The patient expressed concern about potential future infertility. At age 9, she was diagnosed with a viral infection by an ENT specialist due to bilateral hearing loss, leading to emotional disturbances. There was no history of prior medication, family illness, or chronic infections. Born at term via spontaneous vaginal delivery, the patient weighed 3,000 grams. Laboratory tests revealed normal T3 (1.51 ng/dl), FT4 (1.16 ng/dl), prolactin (18.25 ng/ml), estrogen (11 pg/ml), and progesterone (0.1 pg/ml) levels, but elevated FSH (66.46 mIU/ml) and LH (29.97 mIU/ml) levels. Symptomatic treatment included bone conduction hearing aids and estrogen replacement therapy. Conclusion: Perrault Syndrome, a rare hereditary condition, manifests as sensorineural hearing loss (SNHL) and ovarian dysfunction, including primary ovarian insufficiency (POI) and gonadal dysgenesis, in individuals with a 46, XX karyotype. Molecular diagnosis remains challenging. Consultation with a pediatric endocrinologist can guide cyclic estrogen and progesterone therapy to induce withdrawal bleeding in adolescents with amenorrhea. Women at risk of ovarian failure should consider donor eggs or oocyte cryopreservation. Avoiding aminoglycosides and excessive noise is crucial for managing hearing loss.

  • Open Access

    Left hemiparesis due to space-occupying lesion in pregnancy

    by Luminto, Ekarini Aryasatiani, Mahendro Aji Panuntun, Bobby Wirawan Hassan, Tania Sananta, Arya Elbert Neil

    HIGHLIGHTS 1. Present a case report detailing the diagnosis and management of a space-occupying lesion identified late in pregnancy.2. Current studies consistently indicate that the optimal period for tumor removal during pregnancy is the second trimester, balancing maternal and fetal outcomes. This case report contributes to the existing literature by providing a practical reference for managing space-occupying lesions in accordance with the latest evidence. ABSTRACT Objectives: The objective of this study was to present the findings from cases of space-occupying lesions (SOL) that were diagnosed late in pregnancy. This case report aimed to highlight the importance of considering space-occupying lesions as a differential diagnosis in instances of hemiparesis during pregnancy, thereby raising clinical awareness and improving diagnostic accuracy. Case Report: A female patient aged 30 years 34 weeks pregnant came with complaints of slurred speech since 3 months before entering the hospital accompanied by weakness in the left limbs since 3 months before admission. The patient felt weak and fell in the bathroom 2 times, at the office and at home. The patient had a history of taking aspilet for 1.5 months due to a misdiagnosis as a stroke in a Type B hospital and stopped when she came to the obstetric emergency room at a Type A Hospital for the first time. Cardiothoracograph examination shows a picture of a silent baby. Computed Tomography (CT) Scan examination showed a picture of hydrocephalus. Conclusion: To date, it has not been proven that pregnancy triggers brain tumors. However, increased blood supply to the brain during pregnancy may lead to tumor growth. This is also evident in this case where there is an increase in maternal blood volume and subsequent cerebral blood flow, causing an increase in the size of the SOL. On the other hand, there is no evident that brain tumors directly harm the fetus, though fetal hypoxia may occur indirectly due to maternal respiratory failure.